(Q36695300)

15 August 2017

Predicting aggressive outcome in T1N0M0 breast cancer (English)

1 reference

15 August 2017

T Kuopio

2

0 references

author name string

P Kronqvist

1

1 reference

15 August 2017

M Nykänen

3

1 reference

15 August 2017

H Helenius

4

1 reference

15 August 2017

J Anttinen

5

1 reference

15 August 2017

P Klemi

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

91

1 reference

15 August 2017

2

1 reference

15 August 2017

277-281

1 reference

Prognostic and predictive indicators in operable breast cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

New prognostic factors for breast cancer recurrence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Pathology characteristics that optimize outcome prediction of a breast screening trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Development and validation of a sensitive immunohistochemical oestrogen receptor assay for use on archival breast cancer tissue.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Trends in breast cancer aggressiveness before the introduction of mass screening in southeastern Netherlands 1975-1989.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Hormone receptor status in primary breast cancer--time for a consensus?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Who should not receive adjuvant chemotherapy? International databases.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

Statistical methods in cancer research. Volume I - The analysis of case-control studies.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409808

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples

5 September 2018

1 reference

12 December 2020

Significant improvement in breast cancer survival through population-based mammography screening

1 reference

12 December 2020

Her-2/neu oncogene amplification and protein over-expression in interval and screen-detected breast cancers

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy

1 reference

12 December 2020

Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601948

0 references

1 reference

15 August 2017

PubMed publication ID

15199391

1 reference